| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.71B | 25.65B | 27.43B | 26.39B | 25.65B | 18.08B |
| Gross Profit | 10.87B | 11.69B | 11.55B | 6.75B | 13.93B | 4.24B |
| EBITDA | 5.15B | 5.30B | 6.18B | 4.64B | 8.13B | 3.93B |
| Net Income | 3.30B | 3.79B | 3.44B | 2.25B | 5.07B | 1.67B |
Balance Sheet | ||||||
| Total Assets | 33.96B | 31.77B | 28.32B | 26.54B | 28.21B | 25.41B |
| Cash, Cash Equivalents and Short-Term Investments | 10.33B | 9.30B | 4.50B | 2.78B | 1.62B | 1.38B |
| Total Debt | 4.35B | 3.89B | 2.37B | 3.41B | 4.90B | 6.79B |
| Total Liabilities | 8.77B | 8.20B | 7.04B | 7.50B | 10.76B | 12.69B |
| Stockholders Equity | 25.10B | 23.48B | 21.20B | 18.73B | 17.15B | 12.42B |
Cash Flow | ||||||
| Free Cash Flow | 682.00M | 4.70B | 3.99B | 1.51B | 3.03B | 1.71B |
| Operating Cash Flow | 3.31B | 5.85B | 5.12B | 1.51B | 3.90B | 2.07B |
| Investing Cash Flow | -3.29B | -5.62B | -2.09B | 1.40B | -1.06B | -1.06B |
| Financing Cash Flow | 35.60M | -679.30M | -2.59B | -2.91B | -2.84B | -993.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ₹27.44B | 8.35 | ― | 1.65% | 21.44% | -46.24% | |
68 Neutral | ₹72.48B | 15.33 | ― | 1.05% | -6.18% | -23.70% | |
67 Neutral | ₹28.95B | 13.58 | ― | 1.36% | -0.46% | 4.85% | |
62 Neutral | ₹43.17B | 20.39 | ― | 0.28% | 6.44% | 36.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ₹78.36B | 28.77 | ― | ― | 20.00% | 1413.14% | |
39 Underperform | ₹22.19B | 172.94 | ― | ― | -27.80% | -365.69% |